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Diseases of the bile duct (cholangiopathies) remain a common indication for liver
transplantation, while little progress has been made over the last decade in
understanding the underlying pathophysiology. This is largely due to lack of proper
in vitro model systems to study cholangiopathies. Recently, a culture method has
been developed that allows for expansion of human bile duct epithelial cells grown
as extrahepatic cholangiocyte organoids (ncECOs) in non-canonical Wnt-stimulating
conditions. These ncECOs closely resemble cholangiocytes in culture and have shown
to efficiently repopulate collagen scaffolds that could act as functional biliary tissue in
mice. Thus far, initiation of ncECOs required tissue samples, thereby limiting broad
patient-specific applications. Here, we report that bile fluid, which can be less invasively
obtained and with low risk for the patients, is an alternative source for culturing ncECOs.
Further characterization showed that bile-derived cholangiocyte organoids (ncBCOs)
are highly similar to ncECOs obtained from bile duct tissue biopsies. Compared
to the previously reported bile-cholangiocyte organoids cultured in canonical Wnt-
stimulation conditions, ncBCOs have superior function of cholangiocyte ion channels
and are able to respond to secretin and somatostatin. In conclusion, bile is a new,
less invasive, source for patient-derived cholangiocyte organoids and makes their
regenerative medicine applications more safe and feasible.
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INTRODUCTION
Cholangiopathies are associated with significant morbidity and mortality (Murray and Carithers,
2005; Levitsky, 2011). Insight in the underlying pathophysiology and treatment options is
incomplete, mostly due to the lack of good model systems to culture and expand primary human
cholangiocytes (Sampaziotis et al., 2015). Recently, Sampaziotis et al. (2017) described a method
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to expand primary human cholangiocytes from extrahepatic
bile duct biopsies and culture them as three-dimensional (3D)
organoids. These so-called extrahepatic cholangiocyte organoids
(ncECOs) retained most biliary characteristics in culture and
were successfully used to bioengineer artificial ducts that, after
transplantation in mice, act as functional bile ducts. The culture
of ncECOs is driven by non-canonical Wnt-signaling (ncECOs)
stimulated by R-spondin in combination with Dickkopf-related
protein-1 (DKK-1). Also in vivo, non-canonical Wnt-stimulation
is important for cholangiocyte homeostasis and proliferation
responses to bile duct injury (Cui et al., 2011; Strazzabosco and
Fabris, 2012). Although highly effective, to grow these organoids
either a tissue biopsy from the gallbladder or a brush via
an endoscopic retrograde cholangiopancreatography (ERCP) is
needed (Sampaziotis et al., 2017; Tysoe et al., 2019). These options
are potentially harmful to patients (Seeff et al., 2010) or are
procedures not regularly performed. This limits broad patient-
specific disease modeling and regenerative medicine applications.
To avoid the need for tissue-derived samples, we explored the use
of human bile as an alternative, less invasive, source for patient-
derived ncECOs. A recent study published by Soroka et al. (2019)
showed feasibility of culturing cholangiocyte organoids from bile,
obtained by ERCP. The expansion of these bile-derived organoids
were driven by canonical Wnt-signaling originally described
for the growing intrahepatic cholangiocyte organoids (cICOs)
(Huch et al., 2015). This canonical Wnt-signaling is stimulated
by R-spondin, providing a cholangiocyte with a more stem cell-
like phenotype compared to in vivo cholangiocytes (Sato et al.,
2009, 2011; Barker et al., 2010; Soroka et al., 2019; Rimland
et al., 2020). Moreover, these canonical Wnt stimulation culture
conditions will likely result in a different cell phenotype than
observed under non-canonical Wnt conditions (Sampaziotis
et al., 2017). Since bile duct tissue-derived ECOs cultured in
canonical-Wnt conditions (cECOs) do upregulate Wnt-target
genes, while ncECOs do not (Sampaziotis et al., 2017; Verstegen
et al., 2020). Currently, it is unknown whether under non-
canonical Wnt-stimulated conditions cholangiocyte organoids
can be expanded from bile and retain a more cholangiocyte-like
phenotype. Therefore, the aim of this study is to initiate and
expand non-canonical Wnt driven cholangiocyte organoids from
bile (ncBCOs) and to compare these to canonical-Wnt driven bile
cholangiocyte organoids (cBCOs) from the same bile samples and
to ncECOs from (paired) bile duct tissue.
MATERIALS AND METHODS
Bile and Tissue Collection
Fresh bile (1 ml) was collected from patients receiving an ERCP
(n = 8) for their regular treatment (complete list of patients see
Supplementary Table 1). In addition, bile (3 ml) was collected
ex vivo from gallbladders after surgical removal (n = 8). Bile
from gallbladders was collected from donor livers allocated
for liver transplantation (n = 8). Additionally, tissue samples
were collected from gall bladders (n = 5), either collected after
cholecystectomy (n = 1) at the IJsselland Hospital, Capelle aan
de IJssel, Netherlands, or were along with liver biopsies (n = 3)
or extrahepatic bile duct (EHBD, n = 4) biopsies, collected from
gall bladders from donor livers allocated for liver transplantation
(n = 4). All bile samples were stored immediately on ice and
were processed as soon as possible after collection. All patients or
their next of kin consented with the use of their bile or tissue for
research purposes by signing an informed consent, and the use
of this material was approved by the Medical Ethical Committee
of the Erasmus MC, Rotterdam (MEC-2014-060, MEC-2016-743,
and MEC 2018-1174).
Generation and Culture of Canonical and
Non-canonical Wnt Stimulated
Cholangiocyte Organoids From Bile and
Tissue
For the initiation (of culture) of canonical Wnt stimulated bile
or intrahepatic or extrahepatic bile duct tissue cholangiocyte
organoids (cBCOs, cICOs, and cECOs, respectively), and non-
canonical Wnt stimulated extrahepatic bile duct tissue (ncECOs),
we used protocols similar to the ones previously published (Huch
et al., 2015; Sampaziotis et al., 2017; Soroka et al., 2019; Rimland
et al., 2020; Verstegen et al., 2020). For detailed methodology,
please refer to Supplementary Material and Methods. Human
ncBCOs (n = 16) were cultured from 1 ml (ERCP) or 3 ml of
bile (gallbladder), depending on the source. Bile was centrifuged
at 453 g for 5 min at 4◦C, supernatant was removed, and
the cell pellet was washed twice with excess cold William’s-
E medium (WE). Finally, the pellet was suspended in WE
and filtered through a 70-µm cell strainer to remove debris.
Afterward, cells were plated out in a 25-µl droplets of basement
membrane extract (BME, Cultrex) and culture medium (WE
with supplements) was added according to the standard ncECO
protocol (Sampaziotis et al., 2017; Tysoe et al., 2019). Medium
was changed twice a week, and cultures were split in a 1:2 to
1:10 ratio depending on the number and size of organoids grown.
Cultures were routinely checked for mycoplasma contamination,
which came back negative. All experiments with ncECOs and
ncBCOs were performed with passage five or higher, unless
stated otherwise. For a complete overview of the nomenclature
and culture conditions for cholangiocyte organoids and patient
characteristics, see Supplementary Tables 1, 3.
Flow-Cytometry of Bile-Derived Cells
and ncBCOs
Fresh human bile was obtained from patients immediately
after collection via ERCP (n = 3) and stored at 4◦C during
transportation. Bile was transferred to a 15 mL Falcon tube and
centrifuged for 5 min at 4◦C, supernatant was removed, and
the cell pellet was washed twice with WE. ncBCOs were made
single cell by incubation with Trypsin-EDTA (TE) for 25 to
40 min, at 37◦C. Cells were washed in WE and put through a cell
70 µm cell strainer. Samples were blocked in 1% bovine serum
albumin (BSA)-Phosphate-buffered saline (PBS) for 15 min.
TROP2 antibody (Invitrogen; rabbit monoclonal conjugated to
Alexa Fluor-488, clone MR54, used 1:100) was added (30 min,
on ice), and cells were subsequently measured on a Canto flow
cytometer (BD Biosciences).
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RNA Extraction, cDNA Synthesis, and
RT-qPCR
RNA was harvested by the addition of 700 µl of QIAzol lysis
reagent (Qiagen) per two 25-µl domes of ncECO (n = 6), ncBCO
(n = 6), and cBCOs (n = 6). RNA extraction and subsequent
cDNA synthesis was performed as previously published (Roest
et al., 2019). In short, RNA was isolated using an miRNeasy
kit (Qiagen) according to the manufacturer’s protocol. RNA
concentration was measured using a NANOdrop 2,000 (Thermo
Fisher). cDNA (500 ng) was prepared using 5× PrimeScript
RT Master Mix in a 2,720 thermal cycler (Applied Biosystems).
RT-qPCR was performed with the primer sets provided in
Supplementary Data Table 2. All RT-qPCR data are presented
as mean with a 95% confidence interval. RT-qPCR values
are relative to the housekeeping gene Hypoxanthine-guanine-
fosforibosyl-transferase (HPRT) or Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and for visual interpretation multiplied
by 105 or 106.
Immunohistochemistry
Immunohistochemistry (IHC) was performed according to
standard procedures as previously described for cICOs; liver
biopsies obtained from donors allocated for transplantation were
taken along as control (Huch et al., 2015). In short, formalin-
fixed, paraffin-embedded bile duct biopsies were sectioned (4 µm
thick) and processed according to standard procedures. Antigen
retrieval was performed in citrate buffer (pH 6.0) for 10 min in
sub boiling temperatures and non-specific reactions were blocked
by incubation with 10% goat serum in a 1% BSA-PBS solution.
The sections were exposed to primary antibodies overnight at
4◦C Cytokeratin (KRT)19 and KRT7 antibodies (both Dako were
used in 1:100 dilution in 1% BSA-PBS). The antibody for Cystic
Fibrosis Transmembrane Conductance Regulator (CFTR, EMD
Millipore Corp.) was used in a 1:200 dilution of 1% BSA-PBS.
Sections were subsequently incubated with Envision + system
horseradish peroxidase anti-mouse secondary antibody (Dako)
at room temperature for 60 min, before staining with 3′-
diaminobenzidine (DAB). Nuclei were stained by hematoxylin.
Analysis was done with a Carl Zeiss Axioskop 20 microscope, and
images were taken with a Nikon Digital Side DS-5M camera.
Gene-Array Selection-Based qRT-PCR
Twenty genes were selected from the online published
Microarray gene expression data corresponding to the heat
map (Figure 1D) published in Sampaziotis et al. (2017). Out of
the gene-expression heatmap, 10 genes were selected, which have
a similar expression between primary human cholangiocytes and
ncECOs, five genes were selected, which have higher expression
in ncECOs compared with primary human cholangiocytes and
five genes, which have lower expression in ncECOs compared
with primary human cholangiocytes. Additionally, 15 genes
known to be Wnt-target/stem cell-related or hepatocyte and
cholangiocyte specific, were selected (Huch et al., 2015), and their
expression was assessed by RT-qPCR. The selected genes and
correlating primer sets are listed in Supplementary Data Table 2.
The details on the ncECOs and ncBCOs used are described in
Supplementary Data Table 1. A Z-stack heat-map was created
by unsupervised hierarchical clustering in R (version 3.5.1, R
Core Team) supplemented with package Gplots (version 3.0.1).
Swelling of Cholangiocyte Organoids
To assess functionality of secretin and somatostatin, a slight
modification of the Forskolin-Induced Swelling (FIS) assay as
developed by Dekkers et al. (2013) was applied. For this, ncECOs
and ncBCOs organoids were incubated for 30 min with 3 µM
calcein-green (Invitrogen), stimulated with secretin (10 µM) or
secretin and somatostatin (100 µM) and analyzed by confocal
live cell microscopy at 37◦C for 120 min (LSM710, Zeiss).
The total or single organoid area (XY plane) increase relative
to t = 0 of secretin treatment was quantified using velocity
imaging software (Improvision) and compared to non-stimulated
controls. Cell debris and unviable structures were manually
excluded from image analysis.
Gamma-Glutamyltransferase Assay
Ten microliters of supernatant of cholangiocyte organoids from
bile (ncBCOs, n = 3) and from tissue (ncECOs, n = 3)
were collected. Next, Gamma-glutamyltransferase (GGT) activity
colorimetric assay kit (MAK089; Sigma-Aldrich) was used
according to the manufacturer’s protocol.
Rhodamine 123 Transport Assay
Functionality of the multi drug resistance-1 (MDR-1) transporter
was performed according standard protocol using a commercially
available Rhodamine 123 assay (Sigma Aldrich) (Sampaziotis
et al., 2017). Rhodamine 123 transport was determined by
incubating the cultures with Rhodamine 123 (100 µM, Sigma
Aldrich) for 5◦min at 37◦C. Subsequently, specificity of the MDR-
1 transporter was determined by blocking the transporter with
Verapamil (10◦µM, Sigma Aldrich) for 30◦min at 37◦C prior to
Rhodamine 123 incubation (100◦µM, Sigma Aldrich). Confocal
analysis was performed to determine MDR-1 activity. Images
were acquired with a Leica SP5 confocal microscope (LEICA)
equipped with a 488-nm laser.
Ussing Chamber Assay
Extrahepatic cholangiocyte organoids, ncBCOs, cICOs, and
cBCOs (all n = 3) were collected from 10–25 µl domes. Organoids
were collected in WE, centrifuged (453 g, 5 min, 4◦C) and
the supernatant was removed. Organoids were mechanically
broken by pipetting up and down and were spun down again.
A single cell suspension was made through incubation of the
organoids in 1 ml TE for 25 to 40 min, at 37◦C. Cells were
washed in WE and put through a cell 70 µm cell strainer.
Approximately, 3 × 105 cells were resuspended in 200 µm
WE-medium with supplements (Sampaziotis et al., 2017) and
seeded on Transwell inserts (24-well plate 6.5 mm, Corning).
Medium was changed twice per week. To check confluency,
electrophysiological analysis (TEER) was performed after 4 days.
The confluent Transwells were placed in an Ussing chamber
set up to analyze functional cholangiocyte-specific transporter
channels (CFTR and Ca2+ dependent Cl− channel) using
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FIGURE 1 | Creation and culturing of bile cholangiocyte organoids in non-canonical Wnt stimulating conditions (ncBCOs). (A) Schematic representation of initiation
of ncBCOs from endoscopic retrograde cholangiopancreatography (ERCP) collected bile. First bile is collected via an ERCP-procedure (1 ml) Organoid-initiating cells
(viable cholangiocytes) are present in bile and bile should be quickly transferred on ice for processing. Next the bile was diluted and washed a total of three times
with William’s-E medium, to remove all bile from the cells. If a lot of debris is present, additional cells could be passed through a 70 µm cell strained. Subsequently, a
hydrogel (Matrigel, Corning or base membrane extract, Cultrex) is added and the cells are plated out in 25 µl of hydrogel droplets and cholangiocytes are expended
as organoids. (B) (i) A representative image of ncBCOs at passage 0 (P0) after 5 days in culture. (ii) P5 ncBCOs showing mostly cyst-like organoids. (iii) A
representative of an extrahepatic cholangiocyte organoid in non-canonical Wnt stimulating conditions (ncECO) P3. (iv) ncECO passage P5. All scale bar indicates
1,000 µm. (C) (i) Trop2 flow cytometry of all cells counted as an event in bile, indicating that Trop2pos cells are dominantly present in bile, in (ii) the mean percentage
of Trop2poscells in ncBCOs are displayed. (D) Number of passages of the 13 ncBCOs cultured before cryopreservation and storage.
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Acquire and Analyze Software 2.3 (Physiologic Instruments, San
Diego, CA, United States). For detailed methodology of the
conditions, please see Supplementary Material and Methods.
RNA Isolation for Microarray
Total RNA was isolated from cECOs using the miRNEAsy mini
kit (Qiagen, Hilden, Germany) according to the manufacturer’s
protocol and eluted in 30 µl of RNAse-free water. RNA
concentration and integrity were determined using a Nanodrop
2000 (Thermo Fisher Scientific, Waltham MA, United States)
and a Bioanalyzer 2,100 (Agilent Technologies, Santa Clara CA,
United States), respectively. A total of 300 ng RNA was reversed
transcribed, amplified, and biotin-labeled using the Illumina
TotalPrep RNA Amplification Kit (Ambion-Life Technologies,
Carlsbad CA, United States) according to the manufacturer’s
guidelines. HumanHT-12 v4 Expression BeadChips (Illumina,
San Diego CA, United States) were overnight hybridized with
750 ng cRNA, washed, stained, and scanned on an iScan and
analyzed using GenomeStudio V2011.1 software (both from
Illumina, Inc.).
Microarray Analysis
Microarray analysis was based upon the publically available
data of ncECOs from ArrayExpress E-MTAB-4591 [Sampaziotis
et al. (2017), Nature Medine 2017, n = 3], cICOs (n = 3)
from the ArrayExpress E-MTAB-9044 (Roos et al. unpublished),
and the novel data generated for cECOs (deposited at Array
Express, E-MTAB-9807). Bead types missing in one or more
arrays were excluded, and the resulting non-normalized raw
probe data set was combined with the open datasets. The
file, describing for each probe AVG_Signal and Detection Pval,
was loaded into R using the limma package (Ritchie et al.,
2015). limma powers differential expression analyses for RNA-
sequencing and microarray studies. Nucleic Acids Research 43,
e47). Probes that were present at least once (Detection Pval
<0.01) were considered as being expressed (21,929 probes) and
used for further analysis. Following filtering, the data were
background subtracted, normalized, and log2 transformed using
the VSN package (Huber W, von Heydebreck A, Sueltmann H,
Poustka A, Vingron M (2002). “Variance Stabilization Applied
to Microarray Data Calibration and to the Quantification of
Differential Expression.” Bioinformatics, 18 Suppl. 1, S96-S104).
The heatmap was conducted in R using heatmap.2 functions.
Statistical Analysis
All analyses were conducted using SPSS software (statistical
Product and Service solutions, version 22, SSPS Inc., Chicago,
IL, United States), and graphs were performed using GraphPad
Prism 7.0 (GraphPad Software Inc., United States). Continuous
variables were tested using an independent T-test or Mann–
Whitney-U test and presented with normal distribution as
means with standard error of the mean and if not normally
distributed, they are presented as range. Gene array unsupervised
hierarchical clustering data was statistically analyzed using
Pearson’s correlation was calculated between the eight samples





Conditions Can Successfully Be
Expanded From Human Bile
In Figure 1A, a schematic overview of the culture protocol for
bile cholangiocyte organoids (ncBCOs) from bile is displayed.
As shown in Figure 1B, ncBCOs could be successfully cultured
from bile obtained from multiple organ donors or patients with
different underlying liver or biliary diseases (n = 15). Donor,
patient, and culture characteristics are shown in Supplementary
Data Table 1. NcBCOs could be initiated from both ERCP- and
gallbladder bile with a high success rate (15 from 16, 94%).
Morphologically ncECOs and ncBCOs looked similar under
bright-field microscopy (Figure 1B). Recent evidence showed
that primary human cholangiocytes are Trop2 positive (Aizarani
et al., 2019). Thus, to investigate if primary cholangiocytes
are present in bile we looked at Trop2pos cells. As shown
in Figure 1C, the Trop2pos cell population was the highly
dominated population within the bile samples (mean percentage
62.20 ± 2.69). To confirm that ncBCOs resemble their Trop2pos
organoid-initiating population in vitro, we performed flow
cytometry analysis on ncBCOs. As indicated by Figure 1C,
almost all cells found within organoids are indeed Trop2pos
(mean percentage 95.43 ± 0.67) highlighting their resemblances
to primary cholangiocytes. Similar to ncECOs, ncBCOs rapidly
expanded and could be passaged approximately one time a week
in a 1:3 ratio. ncBCOs could be passaged for at least 15 passages
(>3 months) (Figure 1D).
ncBCOs and ncECOs Have Similar Gene-
and Protein-Expression Profiles
To determine the phenotype of ncBCOs, gene-expression of a
selected number of cholangiocyte-specific genes was assessed
and compared to ncECOs using qRT-PCR (Sampaziotis et al.,
2017). Organoid lines included for qRT-PCR analysis were
almost all (four out of six) paired from the same donor to
overcome donor variances. Additionally, samples were from
patients with a similar disease (ncBCO8 and ncECO11), or with
a relatively healthy bile duct (ncBCO10 and ncECO12). Details
of the origin of the organoids are shown in Supplementary
Table 1). Expression of cholangiocyte markers KRT19, KRT7, and
hepatocyte nuclear factor-1beta (HNF1β), CFTR, Trefoil Factor 1
(TFF1), Trefoil Factor 2 (TFF2), and biliary progenitor marker
sex-determining region Y (Sox)9 was assessed. As shown in
Figure 2A, these cholangiocyte markers were highly expressed in
ncECOs and ncBCOs and no significant differences in expression
was observed. As a control, the expression of hepatocyte
markers albumin (ALB) and CYP3A4 compared to liver-tissue
biopsies, as well as the Wnt-target gene leucine-rich repeat-
containing G-protein coupled receptor 5 (LGR5) and the stem
cell marker prominin-1, also known as CD133, was determined
(Figure 2B). Compared to liver biopsies that mostly consists of
hepatocytes, the expression of the hepatocyte markers albumin
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FIGURE 2 | Gene and protein expression between bile-derived cholangiocyte organoids (ncBCOs) and extrahepatic cholangiocyte organoids (ncECOs) is similar.
(A) Gene expression profiles of selected genes between ncECOs (n = 6) and ncBCOs (n = 6) for eight mature cholangiocyte-related genes relative to the reference
gene hypoxanthine-guanine-fosforibosyl-transferase (HPRT ) (for characteristics of organoid lines or gene and primer details see Supplementary Data Tables 1, 2).
Error bars are presented as standard error of the mean (SEM). (B) Gene expression profiles of selected hepatocyte and stemness/Wnt-target-genes between
ncECOs (n = 6), ncBCOs (n = 6), and liver-biopsies (n = 3) relative to the reference gene HPRT, indicating that ncECOs and ncBCOs have very low expression of
hepatocyte-related genes: Albumin and Cyp3A4, and they have similar expression of stemness/Wnt-target-related genes. Error bars are presented as SEM.
(C) Gene-expression profiles of ncBCOs and ncECOs are highly similar for these 35 selected genes. The included genes were selected based on published results
by Sampaziotis et al. (2017) Figure 1D along with additional Wnt-target, cholangiocyte and hepatocyte related genes (Huch et al., 2015) and were quantified by
qRT-PCR (see Methods and Supplementary Data Table 2). Euclidean hierarchical clustering did not show a significant segregation of gene-expression between
ncECOs and ncBCOs. (D) Immunohistochemistry (IHC) staining of cystic fibrosis transmembrane conductance regulator (CFTR) in ncBCOs showing polarization of
our organoids and luminal CFTR expression, similar to liver biopsies, top row scale bars indicate 200 µm, bottom scale bars indicate 50 µm.
(E) Immunohistochemistry of ncBCOs and ncECOs showing comparable staining of cytokeratin, (KRT)19, and KRT7. Moreover, it reveals a columnar-like cell,
resembling primary cholangiocytes as shown on liver tissue coupes. All scale bars in IHC pictures of ncECOs and ncBCOs represent 25 µm, and all scale bars from
the liver biopsy pictures represent 100 µm.*Statistical significant difference (P < 0.05).
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and Cyp3A4 was 17,500–114,970 times and 32–260 times lower
in ncECOs and ncBCOs, respectively (Figure 2B), highlighting
the resemblance of ncECOs and ncBCOs with cholangiocytes.
Furthermore, no differences in gene-expression for LGR5 and
CD133 could be determined between ncECOs and ncBCOs. To
further confirm that ncBCOs have a similar gene expression
profile as ncECOs, the expression of 35 genes (for gene selection
see Material and Methods) was determined in ncBCOs and
ncECOs using cluster analyses. Pearson correlation coefficient
showed no major differences between the expression of these
genes in both organoid types (Figure 2C). To confirm that the
organoids are polarized, a CFTR-staining was performed, as
shown in Figure 2D. CFTR is predominantly expressed on the
luminal side of our ncBCOs, resembling the in vivo situation
in the liver (Figure 2D). Furthermore, IHC staining of KRT7
and KRT19 confirmed expression of both cholangiocyte markers
in the cytoplasm of ncBCO and ncECOs. Moreover, histology
revealed a typical columnar-like epithelium in the organoids, with
the nucleus located basolateral, similar to primary cholangiocytes
in tissue biopsies (Figure 2E) (Boyer, 2013).
Both ncBCOs and ncECOs Have
Cholangiocyte Functionality in vitro
Cholangiocytes influence bile quality by secretion of ions via
either CaCl and Anoctamin-1 (ANO1) transporter channels
or via an increase of cAMP, which regulates CFTR (Boyer,
2013). Basolateral secretin and somatostatin receptors regulate
intracellular cAMP concentrations (Boyer, 2013). As displayed
in Figures 3A,B, ncBCOs responded to stimulation of secretin
similar to the in vivo situation by showing an increase
(2.21 ± 0.48 fold change) in diameter (t = 120) compared to
t = 0 min. The ncECOs responded similarly (mean fold change
1.74 ± 0.22). Addition of somatostatin reduced the induced
swelling (1.69 ± 0.187 increase in ncBCOs and 1.41 ± 0.14
for ncECOs), confirming functional secretin and somatostatin
receptors in ncBCOs.
The capability to export drugs was confirmed in ncBCOs by
imaging effective transport of Rhodamine 123 by the multidrug
resistance protein-1 (MDR1) (Sampaziotis et al., 2017). The
complete abrogation of fluorophore transport to the lumen of
the organoids by Verapamil, confirmed MDR-1 dependency
(Figure 3C). Both findings are in line with the previously
published results for ncECOs (Sampaziotis et al., 2017).
Previous work by Sampaziotis et al. (2017) showed that
activity of GGT in ncECOs is similar to primary cholangiocytes.
To investigate if the GGT activity of ncBCOs is in line with
ncECOs, we cultured both ncECOs and ncBCOs and analyzed
the culture supernatant for GGT-activity. As shown in Figure 3D
we demonstrate that GGT excretion is similar between ncBCOs
and ncECOs (7.77± 1.10 vs. 8.59± 0.34, p = 0.63) as measured by
ELISA. Since the activity of ncECOs and primary cholangiocytes
is also similar, it seems plausible that ncBCOs resemble GGT
activity similar to that of primary cholangiocytes.
Organoids are normally grown in a 3D setting, making it
difficult to access the cells’ luminal side. In cholangiocytes, both
the ANO1 and CFTR channel are located at the luminal side.
To overcome the hurdle of accessing this side, both ncBCOs
and ncECOs were grown as 2D monolayers and ion-channel
functionality was addressed in an Ussing chamber. As shown in
Figure 3E, ncECOs and ncBCOs both responded to activation
with forskolin (cAMP-activator), which was completely inhibited
by addition of GlyH-101, a CFTR-inhibitor, to the luminal side.
Additionally, stimulation by UTP (luminal) and inhibition (by
T16Ainh-A01, luminal) demonstrated the presence of functional
ANO1 in both organoid types. Combined, this demonstrates that
ncBCOs and ncECOs are very similar type organoids that both
represent cholangiocyte-like characteristics.
ncBCOs Retain Secretin Receptor
Responsiveness and Increased
Ion-Channel Activity in vitro Compared
to cBCOs
Soroka et al. (2019) created bile-cholangiocyte organoids
(cBCOs), using the established culture conditions by Huch
et al. created for cICOs (Huch et al., 2015). To investigate if
there are differences between ncBCOs and cBCOs, we created
organoids from bile samples and cultured them using both
protocols (n = 3). We analyzed gene-expression profiles using
qRT-PCR. First, we assessed expression of the Wnt target gene
LGR5 and several cholangiocyte-related genes. As indicated in
Supplementary Figure 1A expression of all genes tested was
similar in ncBCOs and cBCOs (Supplementary Figure 1A). To
investigate potential donor-variations between samples, we also
compared the expression profiles between cECOs and ncECOs
for the same cholangiocyte and Wnt-target genes by micro-array.
As shown in Supplementary Figure 1B, the expression profiles
of biological replicates for both culture conditions did not differ.
Moreover, the overall expression profiles of cECOs and ncECOs
are similar, although the differences in culture conditions seems
to cause clustering of specific genes, indicating that this is
an important factor driving gene-expression profiles. In line
with this observation, the mean gene-expression of functional
cholangiocyte channels, transporters, and enzymes NKCC1,
ASBT, CFTR, GGT, and AQP1 are significantly higher in ncBCOs
compared to cBCOs (Figure 4A). This was an interesting
finding and to further confirm differences in functional receptors
and ion channels, we performed the Ussing chamber assay
using 2D grown ncBCOs and cBCOs. As a control both the
tissue-derived organoids (ncECOs and cICOs) from the original
publications were created (Huch et al., 2015; Sampaziotis et al.,
2017). As shown in Figure 4B and Supplementary Figure 2
only organoids cultured in the non-canonical Wnt-stimulated
medium (ncBCOs and ncECOs) could respond to addition of
secretin and somatostatin. This indicates that functional SCTR
and SSTR are only present in cholangiocyte-organoids cultured
in this specific medium. In contrast, organoid cultured in the
canonical-Wnt stimulated conditions (cICOs and cBCOs) did
not respond to secretin or somatostatin. Moreover, it seems that
although all four-organoid types could respond to forskolin and
this response was specifically inhibited by addition of GlyH-101
(a specific CFTR-inhibitor), demonstrating functional CFTR-
channels in all organoids, this effect was more pronounced
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FIGURE 3 | ncBCOs and ncECOs both have functional cholangiocyte activity. (A) Representative images of selected ncECOs and ncBCOs at time is 0 min, and
time is 120 min of measurements in the secretin and unstimulated (unstimulated) groups. (B) Quantification of organoid swelling in ncECOs and ncBCOs in different
groups, scale bars indicate 50 µm. (C) ncBCOs show clear multi drug resistance-1 (MDR-1) activity as Rhodamine 123 was actively transported out of the cells into
the lumen of the organoid. Specificity was confirmed by inhibition with Verapamil. (D) Gamma-glutamyltransferase (GGT) activity (U/I) as measured by ELISA in both
ncECOs and ncBCOs supernatants (n = 3), scale bars indicate 100 µm. (E) Representative ion-channel functionality of 2D-grown ncBCOs (line 1) and ncECOs (line
2) in an Ussing chamber. Stimulation with cAMP-activator, forskolin, resulted in an increase in short circuit current, demonstrating CFTR-mediated activity (Cystic
Fibrosis Transmembrane conductance Regulator). This was completely blocked by CFTR-inhibitor, GlyH-101. Also, calcium-depended chloride excretion ion channel
activity, specifically stimulated by UTP and inhibited by T16Ainh-A01, was identical between ncBCOs and ncECOs.
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FIGURE 4 | ncBCOs retain secretin receptor responsiveness and increased ion channel activity in vitro compared to cBCOs. (A) qRT-PCR of ncBCOs and cBCOs
(both, n = 6), for cholangiocyte specific channels and transporters. Showing a significant upregulation (p < 0.05, as indicated by *) for AQP1, CFTR, ASBT, NKCC-1,
and GGT in ncBCOs compared to cBCOs. Error bars are displayed as SEM. (B) Representative ion-channel functionality of 2D-grown bile-cholangiocyte organoids
in non-canonical Wnt-stimulated conditions (ncBCOs, line 2) and bile cholangiocyte organoids in canonical-Wnt-stimulated organoids (cBCOs, line 1) in an Ussing
chamber, stimulation with cAMP-activator (forskolin), resulted in an increase in short circuit current; however, secretin stimulation (to the basolateral side) only gave a
response in the ncBCOs. In similar fashion, somatostatin (basolateral addition) only give a response in ncBCOs and not in cBCOs, while CFTR inhibition via
GlyH-101 (luminal addition), resulted in an inhibition of the channel in both organoid-types, indicating the presence of functional CFTR channels in both organoids,
but only somatostatin and secretin receptors are functional in ncECOs. Moreover, it seems that CFTR-function is higher in organoids in non-canonical Wnt
stimulating conditions compared to organoids in canonical-Wnt-stimulating conditions. (C) Heatmap and clustering based expression of cholangiocyte-related gene
expression as analyzed by gene array for functional enzymes (ALPI and GGT1), channels (SLC12A2—also known as NKCC1-, SLC10A2—also known as ASBT-,
AQP1, ANO1, and CFTR) and receptors (SCTR and SSTR) between cICOs (n = 3), cECOs (n = 3), and ncECO (n = 3). Color key represents the log2 transformed
signal intensities after variance stabilizing normalization.
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in organoids cultured under the non-canonical Wnt-stimulated
conditions. To investigate the reason for the differences in
functionality of cholangiocyte organoids in different culture
conditions we looked at gene-expression profiles as analyzed by
gene-array of publically available and novel generated data of
cICOs, cECOs, and ncECOs. All cICOs and cECOs were matched
for donors (n = 3). As shown in Figure 4C, the gene expression
of almost all mature cholangiocyte-related enzymes, channels,
and receptors (Dekkers et al., 2013) was higher in non-canonical
Wnt-related conditions, similar to the results of the qRT-PCR
analysis (Figure 4A). This suggests that lack of functional
SCTR is the result of low or absent SCTR gene expression in
organoids under canonical-Wnt conditions. Interestingly, cICOs
and cECOs cluster together, indicating that culture conditions
overshadows differences related to the region of origin (e.g.,
from intra- or extrahepatic). To further investigate the influence
of culture conditions, we changed the medium in the different
organoid cultures. As shown in Supplementary Figure 3A, it
seems that culture conditions for the classical cholangiocyte
markers do not differ in BCOs, with the exception for the
expression of HNF1β between cBCOs and ncBCOs in this series.
Interestingly, although BCOs are initiated in medium containing
canonical-Wnt stimulation, switching them to non-canonical
Wnt stimulating medium alters the gene-expression profiles for
genes related to function (Supplementary Figure 3B). This
change in medium directed the switched cBCO gene-expression
profile to become more closely related to bile-cholangiocyte
organoids initiated in non-canonical Wnt conditions and
expression of ASBT and GGT was significantly higher under
non-canonical Wnt stimulated conditions. A similar effect for
these genes was observed when switching ncBCOs to canonical
Wnt stimulating conditions (Supplementary Figure 3B). These
results suggest that cholangiocyte-organoids cultured in different
conditions are very similar, but differences might be induced by
the culture conditions.
DISCUSSION
In this study, we demonstrate that primary biliary epithelial
cells (cholangiocytes) collected from bile can be cultured and
expanded efficiently in vitro while retaining their cholangiocyte
characteristics. We show that these ncBCOs, could be efficiently
initiated from ERCP and gallbladder bile and could be cultured
long-term. In addition, we show that ncBCOs have similar
characteristics when compared to ncECOs as described by
Sampaziotis et al. (2017). Similar gene-expression profiles were
found in both types of organoids, and both were found to behave
as cholangiocytes in functional assays. This study furthermore
provides evidence that ncBCOs are distinct from the previously
published cBCOs (Soroka et al., 2019). The non-canonical Wnt
stimulation of ncBCOs seem to preserve the cholangiocyte-
specific basolateral receptor activity in vitro. This is the first
study demonstrating expansion of non-canonical Wnt stimulated
cholangiocyte organoids from bile. Recent publications show
that cholangiocyte organoids in non-canonical Wnt stimulating
conditions can be cultured from intra- and extrahepatic biopsies
as well as from brushes collected from the common bile duct
(Sampaziotis et al., 2017; Tysoe et al., 2019). The use of
biopsies and ERCP brushes as a source for biliary organoids
provides promising source for in vivo collected cholangiocytes
as well. Of note, the use of brushes is associated with more
complications for the patient when compared to the collection
of liquid biopsies from bile (Vandervoort et al., 1999; Korc and
Sherman, 2016). Surgical procedures to obtain gallbladders or
biopsies are especially risk full in patients with advanced liver
cirrhosis (Currò et al., 2005; Strömberg et al., 2015), a potential
target population. This is obviously an unwanted risk which
limits the patient-specific applications. Moreover, bile allows for
inclusion of patients with rare diseases and can model disease-
progression in vitro, as liquid biopsies can be easily collected
during routine (clinical) procedures which patients already
undergo for their regular treatment at progressive time-points.
Thus, ERCP-derived bile is a relatively safe source for patient-
derived cholangiocyte organoids. We show that bile derived
from the gallbladder is also a source of cholangiocyte organoids.
We included gallbladder bile-derived organoids to study donor
variations (Rimland et al., 2020; Verstegen et al., 2020), since
matched collection of gallbladder bile and gallbladder-tissue from
the same patient could be easily accomplished. Some patients
are not eligible for ERCP and thus a percutaneous transhepatic
cholangiography drainage (PTCD) is performed in these specific
patients. Since we demonstrate that multiple sources of bile can
be used for ncBCOs, bile collected via PTCD might represent an
additional source in this specific subgroup.
Cholangiocytes organoids, either initiated from tissue or
bile in both culture conditions, are most likely risen from
primary cholangiocytes (Sampaziotis et al., 2017; Hu et al.,
2018; Aloia et al., 2019; Planas-Paz et al., 2019). In line
with previous publications, we confirmed the presence of
a Trop2pos population in bile, which is considered the
population that resembles primary cholangiocytes (Aizarani
et al., 2019). Since primary cholangiocytes are most likely
the cell-of-origin for these organoid cultures, these are the
culture conditions that are responsible for the difference
in gene-expression and functionality in vitro. ncBCOs are
cultured in medium with components typically stimulating
the non-canonical Wnt-pathway, while cBCOs are cultured in
Wnt/β-catenin stimulated conditions, usually responsible for
maintaining stem cell-like characteristics in cell culture. Recent
evidence indicates that non-canonical Wnt signaling is important
in cholangiocyte homeostasis and proliferation (Pepe-Mooney
et al., 2019; Planas-Paz et al., 2019). Both publications showed
that, although Wnt ligands seem important in homeostasis
of biliary epithelium in vivo, this was independent of the
canonical Wnt-related genes AXIN2, LGR5, and β-catenin. This
demonstrates that it is actually non-canonical Wnt signaling
which drives ductal reprogramming. In contrast, Planas-Paz et al.
(2019) discovered that LGR5-depended Wnt/β-catenin signaling
is necessary for expansion of intrahepatic cholangiocytes,
cultured as cICOs, in vitro. In line with these results
several publications have reported that Wnt/β-catenin-LGR5
signaling is upregulated in canonical-Wnt driven cholangiocyte-
organoid cultures, while markers for mature cholangiocytes
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(like CFTR) are downregulated compared to primary
cholangiocytes (Aizarani et al., 2019; Pepe-Mooney et al., 2019;
Planas-Paz et al., 2019). Thus, suggesting that organoids initiated
under these Wnt/β-catenin stimulated culture conditions
require these specific signals for growth and alter their gene-
expression profile by expressing Wnt/β-catenin related target
genes, although this does not seem to be essential for ductal
reprogramming in in vivo biliary epithelium.
This in vitro study might validate that the use of non-
canonical Wnt cell culture conditions results (for some
aspects) in a more mature cholangiocyte in vitro, compared
to Wnt/β-catenin-stimulated conditions. Here we show that
ncBCO have higher expression of mature cholangiocyte-channel
genes compared to cBCOs. In addition, gene expression as
analyzed by gene-array shows that expression of the functional
cholangiocyte-related genes such as ANO1, NKCC1, CFTR,
GGT, AQP1, and the basolateral receptor SCTR is higher in
non-canonical Wnt-stimulated cholangiocyte organoids when
compared to Wnt/β-catenin cultured organoids from tissue.
Moreover, ncBCOs (and ncECOs) have functionality of the
typical cholangiocyte-receptors: secretin and somatostatin while
cBCOs (and cICOs) do not. Interestingly, our analysis provides
evidence that there is some plasticity in cholangiocyte organoids
since we demonstrate that gene-expression profiles in BCOs
change depending on the culture conditions. In line with our
hypothesis, the functional-related genes ASBT and GGT are
upregulated when culture medium is switched from canonical
Wnt to non-canonical Wnt stimulating compounds. Also
other genes (HNF1β and PROM1) are differently expressed
after switching. Together, our results indicate that culture
conditions most probably drive the expression of specific genes in
cholangiocyte organoids and that cholangiocytes might be more
mature under non-canonical Wnt stimulating conditions. It is
important to note that ncECO were shown capable of forming
functional bile duct tissue in vivo after repopulating collagen
scaffolds and transplantation in mice (Sampaziotis et al., 2017).
The strength of using bile as a minimally invasive source of
organoid-initiation cells for culturing cholangiocyte-organoids, is
that it allows for patient-specific organoid cultures and thereby
avoids immunological responses after transplantation.
In conclusion, our studies confirm and extend the studies
previously reported on ncECOs (Sampaziotis et al., 2017),
demonstrating that these cholangiocyte organoids can efficiently
and reproducibly be initiated from bile collected from patients
with a broad spectrum of underlying biliary diseases. Given that
ncECOs and ncBCOs are highly similar, an important amenity
of ncBCOs is that they are reproducibly initiated from bile,
which is collected relatively easily and in a less invasive manner
opposed to surgically rendered tissue biopsies. Moreover, they
seem to represent a more mature cholangiocyte compared to the
previously published cBCO (Soroka et al., 2019). With this, the
expansion and use of cholangiocyte-organoids that are acquired
with low complication hazard from patients becomes feasible for
personalized disease modeling and regenerative medicine.
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